- Home
- ICHR vs CSTL Comparison
ICHR vs CSTL Comparison
Compare ICHR & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICHR
- CSTL
- Stock Information
- Founded
- ICHR 1999
- CSTL 2007
- Country
- ICHR United States
- CSTL United States
- Employees
- ICHR N/A
- CSTL N/A
- Industry
- ICHR Semiconductors
- CSTL Medical Specialities
- Sector
- ICHR Technology
- CSTL Health Care
- Exchange
- ICHR Nasdaq
- CSTL Nasdaq
- Market Cap
- ICHR 1.0B
- CSTL 848.1M
- IPO Year
- ICHR 2016
- CSTL 2019
- Fundamental
- Price
- ICHR $30.84
- CSTL $24.94
- Analyst Decision
- ICHR Strong Buy
- CSTL Strong Buy
- Analyst Count
- ICHR 8
- CSTL 6
- Target Price
- ICHR $42.50
- CSTL $40.33
- AVG Volume (30 Days)
- ICHR 225.6K
- CSTL 434.0K
- Earning Date
- ICHR 02-04-2025
- CSTL 02-26-2025
- Dividend Yield
- ICHR N/A
- CSTL N/A
- EPS Growth
- ICHR N/A
- CSTL N/A
- EPS
- ICHR N/A
- CSTL 0.21
- Revenue
- ICHR $819,230,000.00
- CSTL $311,878,000.00
- Revenue This Year
- ICHR $5.99
- CSTL $51.29
- Revenue Next Year
- ICHR $15.26
- CSTL N/A
- P/E Ratio
- ICHR N/A
- CSTL $118.55
- Revenue Growth
- ICHR N/A
- CSTL 62.43
- 52 Week Low
- ICHR $26.40
- CSTL $16.97
- 52 Week High
- ICHR $46.43
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- ICHR 45.10
- CSTL 36.58
- Support Level
- ICHR $29.64
- CSTL $23.95
- Resistance Level
- ICHR $33.23
- CSTL $26.52
- Average True Range (ATR)
- ICHR 1.32
- CSTL 2.08
- MACD
- ICHR -0.13
- CSTL -0.36
- Stochastic Oscillator
- ICHR 24.57
- CSTL 11.26
About ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, the United Kingdom, Singapore, Malaysia, Korea, and Mexico, of which a majority of the revenue is generated from Singapore.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.